1. STAT3 and the STAT3‑regulated inhibitor of apoptosis protein survivin as potential therapeutic targets in colorectal cancer (Review)
   Liliana Cortés‑Ballinas et al, 2024, Biomedical Reports CrossRef
2. Long noncoding RNA LNC473 inhibits the ubiquitination of survivin via association with USP9X and enhances cell proliferation and invasion in hepatocellular carcinoma cells
   Hui Chen et al, 2018, Biochemical and Biophysical Research Communications CrossRef
3. SHED‐derived exosomes improve the repair capacity and osteogenesis potential of hPDLCs
   Menghong Wang et al, 2023, Oral Diseases CrossRef
4. The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
   Yueshuang Ke et al, 2019, Cells CrossRef
5. Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer
   Huanhuan Sha et al, 2021, Frontiers in Oncology CrossRef
6. Suppression of Long Noncoding RNA SNHG1 Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma via Increasing PARP6 Expression
   Qian Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Cancer‐associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells
   Limin Wang et al, 2019, Cancer Science CrossRef
8. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer
   Wei Huang et al, 2021, Aging CrossRef
9. Recent Developments in PARP14 Research
   Amanda L Tauber et al, 2020, Future Medicinal Chemistry CrossRef
10. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia
    Osvaldo D. Rivera et al, 2021, Proceedings of the National Academy of Sciences CrossRef
11. Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation
    Arnau Navinés-Ferrer et al, 2022, International Journal of Molecular Sciences CrossRef
12. Functional roles of ADP-ribosylation writers, readers and erasers
    Ping Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
13. TRIM39 is a poor prognostic factor for patients with estrogen receptor‐positive breast cancer and promotes cell cycle progression
    Takuya Ogura et al, 2022, Pathology International CrossRef